How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer

How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer
Veronica C Shim, MD, FACS

 

Spring 2007 - Volume 11 Number 2

https://doi.org/10.7812/TPP/06-085

Since the Halsted radical mastectomy was introduced in 1894,1 breast cancer treatment has undergone major changes. More than a century later, breast conserving surgery is now accepted in the treatment armamentarium of early breast cancer. However, the role of axillary lymph node dissection (ALND) in breast cancer treatment continues to be controversial. The persistent question in this debate is whether we should abandon axillary lymph node evaluation in breast cancer management; I believe we cannot.

 

The Permanente Journal

Sponsored by the eight Permanente Medical Groups, The Permanente Journal advances knowledge in scientific research, clinical medicine, and innovative health care delivery.

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all material published in The Permanente Journal is copyrighted and protected.

The Permanente Press

A peer-reviewed journal of medical science, social science in medicine, and medical humanities, The Permanente Journal (ISSN 1552-5767) is published quarterly by The Permanente Press.


ISSN 1552-5775 Copyright © 2018 thepermanentejournal.org.

The Permanente Press. All Rights Reserved.